EUVIMEDDescoperă EUVIMED
Open access · CC BY 4.0

Bifidobacterium animalis subsp. lactis CECT 8145 BPL1® Laxative Effects in Loperamide-Induced Constipated SD Rats

Andrea Rodenes-Gavidia iD, Anna Mas-Capdevilla iD, Adrián Florit iD, María Enrique López, Daniel González-Hedström iD, Araceli Lamelas iD, Patricia Martorell iD, Empar Chenoll iD, Vanessa Illescas-Armijo iD, Juan Martínez-Blanch iD, Anna Antolín iD, Juan María Alcaide-Hidalgo iD and 3 more

Nutrients · 2026-04-14 · 18 (8) · 1237

DOI: 10.3390/nu18081237 ↗

At a glance

Journal article in Nutrients, published online on 2026-04-14. Written by Andrea Rodenes-Gavidia and 14 co-authors. Institution: ADM R&D Health & Wellness, Parque Científico Universitat de València, Carrer del Catedràtic Agustín Escardino Benlloch, 9, 46980 Paterna, Spain. Major MEDLINE topics: Constipation, Loperamide, Probiotics, Bifidobacterium animalis. 80 references. The full text is freely available (open access, CC BY 4.0).

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

Constipation is a common gastrointestinal (GI) state for which probiotics have shown promise as a relief. This study examined the laxative effects of the strain Bifidobacterium animalis subsp. lactis CECT 8145 (BPL1®) in a loperamide-induced rat model of constipation.

Methods

Fifty-nine rats were divided into control and loperamide-induced constipation groups. Animals received a 3-day intervention with either placebo or probiotic BPL1® at two doses: 1.5 × 108 CFU (colony-forming units) (low) and 3 × 109 CFU (high). The study assessed several parameters to determine the probiotic’s effect, including: stool and gut characteristics, gastrointestinal transit time (GTT), gene expression and gut microbiome composition.

Results

While loperamide significantly decreased stool number, weight and humidity, BPL1® supplementation effectively restored these parameters, being more pronounced at a high dose. Microbiome analysis showed that BPL1® at a low dose reduced the abundance of Muribaculaceae and Muribaculum gordoncarteri, associated with constipation. In addition, Muribaculaceae abundance was negatively correlated with stool humidity. Functional microbiome profiling indicated that BPL1® suppressed pathways related to mucin degradation, vancomycin resistance and isoleucine biosynthesis while promoting L-lactate and pyridoxal-P (vitamin B6) biosynthesis, which may support gut motility and barrier integrity. Conclusions:Bifidobacterium animalis subsp. lactis BPL1® exhibits potential as a functional probiotic for relieving constipation through improving stool excretion and consistency, inducing taxonomic changes and beneficial functional modulation of the intestinal microbiome. These findings justify further investigation into the mechanisms of BPL1® as a probiotic for constipation management.

Subjects

MeSH terms (MEDLINE)

ConstipationLoperamideProbioticsBifidobacterium animalisLaxativesAnimalsRats, Sprague-DawleyMaleGastrointestinal MicrobiomeRatsGastrointestinal TransitDisease Models, AnimalFeces

Author keywords

Bifidobacterium animalis subsp. lactis CECT 8145constipationgut motilitymicrobiome modulationprobiotics

Substances

LoperamideLaxatives

Authors and institutions

  • ADM R&D Health & Wellness, Parque Científico Universitat de València, Carrer del Catedràtic Agustín Escardino Benlloch, 9, 46980 Paterna, Spain.
  • PhD Programme in Biotechnology, Universitat Politècnica de València, Cami de Vera s/n, 46022 Valencia, Spain.
  • Eurecat, Centre Tecnològic de Catalunya, Technological Unit of Nutrition and Health, Avinguda Universitat 1, 43204 Reus, Spain.
  • CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.

ORCID profiles: Andrea Rodenes-Gavidia, Anna Mas-Capdevilla, Adrián Florit, Daniel González-Hedström, Araceli Lamelas, Patricia Martorell, Empar Chenoll, Vanessa Illescas-Armijo, Juan Martínez-Blanch, Anna Antolín, Juan María Alcaide-Hidalgo, Roger Mariné-Casadó, Antonia Rojas, Laura Rago

Cite

APA

Rodenes-Gavidia, A., Mas-Capdevilla, A., Florit, A., Enrique López, M., González-Hedström, D., Lamelas, A., Martorell, P., Chenoll, E., Illescas-Armijo, V., Martínez-Blanch, J., Antolín, A., Alcaide-Hidalgo, J. M., Mariné-Casadó, R., Rojas, A., & Rago, L. (2026). Bifidobacterium animalis subsp. lactis CECT 8145 BPL1® Laxative Effects in Loperamide-Induced Constipated SD Rats. Nutrients, 18(8), 1237. https://doi.org/10.3390/nu18081237

Vancouver

Rodenes-Gavidia A, Mas-Capdevilla A, Florit A, Enrique López M, González-Hedström D, Lamelas A, et al. Bifidobacterium animalis subsp. lactis CECT 8145 BPL1® Laxative Effects in Loperamide-Induced Constipated SD Rats. Nutrients. 2026;18(8):1237. doi:10.3390/nu18081237

BibTeX
@article{RodenesGavidia2026,
  author = {Rodenes-Gavidia, Andrea and Mas-Capdevilla, Anna and Florit, Adrián and Enrique López, María and González-Hedström, Daniel and Lamelas, Araceli and Martorell, Patricia and Chenoll, Empar and Illescas-Armijo, Vanessa and Martínez-Blanch, Juan and Antolín, Anna and Alcaide-Hidalgo, Juan María and Mariné-Casadó, Roger and Rojas, Antonia and Rago, Laura},
  title = {Bifidobacterium animalis subsp. lactis CECT 8145 BPL1® Laxative Effects in Loperamide-Induced Constipated SD Rats},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {8},
  pages = {1237},
  doi = {10.3390/nu18081237}
}
Start for free →